mtl-cebpa
Showing 1 - 4 of 4
Solid Tumor, Adult Trial in London, Newcastle Upon Tyne (MTL-CEBPA, Pembrolizumab)
Active, not recruiting
- Solid Tumor, Adult
- MTL-CEBPA
- Pembrolizumab
-
London, United Kingdom
- +2 more
Apr 4, 2022
Hepatocellular Carcinoma, Hepatitis B, Hepatitis C Trial in Duarte, Singapore (MTL-CEBPA, Sorafenib)
Recruiting
- Hepatocellular Carcinoma
- +2 more
- MTL-CEBPA
- Sorafenib
-
Duarte, California
- +1 more
Feb 20, 2022
Advanced Hepatocellular Carcinoma Trial in Singapore (MTL-CEBPA, Atezolizumab, Bevacizumab)
Recruiting
- Advanced Hepatocellular Carcinoma
- MTL-CEBPA
- +2 more
-
Singapore, SingaporeNational University Hospital
Oct 27, 2021
Hepatocellular Carcinoma, Liver Cancer Trial in Singapore, Taiwan, United Kingdom (MTL-CEBPA, Sorafenib 200mg)
Active, not recruiting
- Hepatocellular Carcinoma
- Liver Cancer
- MTL-CEBPA
- Sorafenib 200mg
-
Singapore, Singapore
- +10 more
Apr 4, 2022